Author: Pfeiffer, Julie K.
Title: Is the Debate and “Pause” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows? Document date: 2015_1_20
ID: vnmc6nqd_1
Snippet: M uch has been said and written about the risks and benefits of certain experiments that alter pathogens with pandemic potential (PPP) (see recent references 1 to 3 and references within). The experiments in question alter transmissibility, virulence, host range, drug susceptibility, immune responses, and/or infectivity or stability. A debate and research "pause" for certain experiments using certain respiratory viruses (influenza, Middle East re.....
Document: M uch has been said and written about the risks and benefits of certain experiments that alter pathogens with pandemic potential (PPP) (see recent references 1 to 3 and references within). The experiments in question alter transmissibility, virulence, host range, drug susceptibility, immune responses, and/or infectivity or stability. A debate and research "pause" for certain experiments using certain respiratory viruses (influenza, Middle East respiratory syndrome [MERS] , and severe acute respiratory syndrome [SARS] viruses) has electrified the scientific community, with strong "propause" advocates, strong "antipause" advocates, and everything in between. This letter is not about whether the experiments, debate, or pause is good or bad. This letter is about the potential impact of the debate and pause on graduate students and postdoctoral fellows and how their future plans may be affected.
Search related documents:
Co phrase search for related documents- acute respiratory syndrome and certain respiratory virus: 1
- acute respiratory syndrome and drug susceptibility: 1, 2, 3, 4, 5
- acute respiratory syndrome and future plan: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute respiratory syndrome and graduate student: 1
- acute respiratory syndrome and host range: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and MERS respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and Middle East MERS respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and pandemic potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and potential impact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome SARS virus and host range: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome SARS virus and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome SARS virus and MERS respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome SARS virus and Middle East MERS respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome SARS virus and pandemic potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute respiratory syndrome SARS virus and potential impact: 1, 2, 3, 4, 5, 6, 7, 8
- benefit risk and MERS respiratory syndrome: 1
- benefit risk and pandemic potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- benefit risk and potential impact: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date